High-throughput method for Antibiotic Susceptibility Testing based on Fluorescein Quenching by Bacteria: Application to Urinary Tract Infection.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 03 2020
Historique:
received: 06 10 2019
accepted: 13 02 2020
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 13 11 2020
Statut: epublish

Résumé

We recently reported a sugar-induced bacterial release of 13-Docosenamide and its ability to quench fluorescein. This simple handle to monitor bacterial growth is readily applicable to develop a quicker antibiotic sensitivity testing method along with a low-cost field-use optical instrumentation. Conditions were standardized to perform this new procedure in the most preferred and CLSI-recommended microdilution format in 12-well strips. A simple and portable optoelectronic prototype was used to capture the image and read the fluorescence signal of the culture medium of the 12-well strips. This new Fluorescence Quenching Method along with the device enabled the choice of the right antibiotic within 8 h of sample collection from the patient. It was compliant to the Clinical Laboratory Standard Institute's quality control guidelines. Clinical assessment of the method using 440 urine samples from Urinary Tract Infection patients against 21 routinely used antibiotics showed a 94.3% match with the results of the Standard Disk Diffusion method. This new method saves the precious time taken for and the cost of antibiotic susceptibility testing for quicker and effective treatment with better compliance.

Identifiants

pubmed: 32132575
doi: 10.1038/s41598-020-60717-9
pii: 10.1038/s41598-020-60717-9
pmc: PMC7055274
doi:

Substances chimiques

Anti-Bacterial Agents 0
Erucic Acids 0
erucyl amide 0V89VY25BN
Fluorescein TPY09G7XIR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4058

Références

English, B. K. & Gaur, A. H. The use and abuse of antibiotics and the development of antibiotic resistance. Advances in experimental medicine and biology 659, 73–82, https://doi.org/10.1007/978-1-4419-0981-7_6 (2010).
doi: 10.1007/978-1-4419-0981-7_6 pubmed: 20204756
Reller, L. B., Weinstein, M., Jorgensen, J. H. & Ferraro, M. J. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clinical infectious diseases 49, 1749–1755 (2009).
doi: 10.1086/647952
Baker, C. N., Stocker, S. A., Culver, D. H. & Thornsberry, C. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. Journal of clinical microbiology 29, 533–538 (1991).
doi: 10.1128/JCM.29.3.533-538.1991
Wayne, P. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-18. Clinical and Laboratory Standards Institute (2008).
Ligozzi, M. et al. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. Journal of clinical microbiology 40, 1681–1686 (2002).
doi: 10.1128/JCM.40.5.1681-1686.2002
Tamilmani, E., Radhakrishnan, R. & Sankaran, K. 13-Docosenamide release by bacteria in response to glucose during growth-fluorescein quenching and clinical application. Appl Microbiol Biotechnol, https://doi.org/10.1007/s00253-018-9127-x (2018).
Sjöback, R., Nygren, J. & Kubista, M. Absorption and fluorescence properties of fluorescein. Spectrochim Acta A 51, L7–L21, https://doi.org/10.1016/0584-8539(95)01421-P (1995).
doi: 10.1016/0584-8539(95)01421-P
Ueno, T. et al. Rational Principles for Modulating Fluorescence Properties of Fluorescein. J. Am. Chem. Soc. 126, 14079–14085, https://doi.org/10.1021/ja048241k (2004).
doi: 10.1021/ja048241k pubmed: 15506772
Kamiya, M. et al. Extension of the Applicable Range of Fluorescein: A Fluorescein-Based Probe for Western Blot Analysis. Angew Chem 44, 5439–5441, https://doi.org/10.1002/anie.200501542 (2005).
doi: 10.1002/anie.200501542
Dafopoulou, K. et al. Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates. Antimicrobial agents and chemotherapy 59, 4625–4630, https://doi.org/10.1128/aac.00868-15 (2015).
doi: 10.1128/aac.00868-15 pubmed: 26014928 pmcid: 4505270
Lo-Ten-Foe, J. R., de Smet, A. M., Diederen, B. M., Kluytmans, J. A. & van Keulen, P. H. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrobial agents and chemotherapy 51, 3726–3730, https://doi.org/10.1128/aac.01406-06 (2007).
doi: 10.1128/aac.01406-06 pubmed: 17646414 pmcid: 2043258
Bulik, C. C. et al. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. Journal of clinical microbiology 48, 2402–2406, https://doi.org/10.1128/jcm.00267-10 (2010).
doi: 10.1128/jcm.00267-10 pubmed: 20484603 pmcid: 2897473
Zhang, S. X. et al. Evaluation of CLSI agar dilution method and Trek Sensititre broth microdilution panel for determining antimicrobial susceptibility of Streptococcus pneumoniae. Journal of clinical microbiology 49, 704–706, https://doi.org/10.1128/jcm.01622-10 (2011).
doi: 10.1128/jcm.01622-10 pubmed: 21123533 pmcid: 3043519
Satlin, M. J. The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future? Journal of Clinical Microbiology 57, e01608–01618, https://doi.org/10.1128/JCM.01608-18 (2019).
doi: 10.1128/JCM.01608-18 pubmed: 30463890 pmcid: 6355526
Cielecka-Piontek, J., Zając, M. & Jelińska, A. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state. Journal of pharmaceutical and biomedical analysis 46, 52–57 (2008).
doi: 10.1016/j.jpba.2007.08.024

Auteurs

Rohit Radhakrishnan (R)

Centre for Biotechnology, Anna University, Chennai, 600 025, India.

Rajesh J (R)

Department of Electronic Systems Engineering, Indian Institute of Science, Bangalore, 560 012, India.

Dinesh N S (D)

Department of Electronic Systems Engineering, Indian Institute of Science, Bangalore, 560 012, India.

Thangavelu C P (T)

Microbiological Laboratory, Coimbatore, Tamil Nadu, 641 002, India.

Sankaran K (S)

Centre for Biotechnology, Anna University, Chennai, 600 025, India. ksankran@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH